Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
BioNTech is a German biotechnology company that specializes in pioneering messenger RNA (mRNA) technology and patient-specific immunotherapies. Best known for co-developing the first widely authorized COVID-19 vaccine alongside Pfizer, the company develops novel treatments for infectious diseases and individualized cancer therapies. Through strategic global partnerships, BioNTech actively advances a robust clinical pipeline to transform precision medicine and healthcare worldwide.